Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: Poland Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20061
20081
20111
20121
20134
20142
20151
20165
20171
20181
20191
20212
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
Novartis Pharmaceuticals4
Sanofi4
Takeda3
Kowa Research Europe2
NewAmsterdam Pharma2
AstraZeneca1
Esperion Therapeutics, Inc.1
Kastle Therapeutics, LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia30
Dyslipidemias12
Hyperlipidemias9
Hyperlipoproteinemia Type II4
Atherosclerosis3
Cardiovascular Diseases2
Homozygous Familial Hypercholesterolemia2
Aortic Valve Stenosis1
Arteriosclerosis1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.